SAN DIEGO — The novel drug Bendavia did not meet any of its primary or secondary endpoints in a trial assessing its use prior to primary PCI in patients with STEMI, according to data presented at the American College of Cardiology Scientific Sessions.Patients…
Source: www.healio.com
Leave a Reply